Evaluation of In Vitro Cytotoxic and Apoptotic Effects of Miltefosine on the Toxoplasma gondii RH Strain
Abstract
Background: We aimed to investigate the cytotoxic and apoptotic effects of miltefosine on Toxoplasma gondii RH strain by various techniques.
Methods: The study was conducted at the Department of Parasitology and Mycology, Urmia University of Medical Sciences, Iran in 2020. Four groups of five BALB/c mice were selected. The cytotoxicity test was conducted by adding miltefosine to T. gondii tachyzoites; control tachyzoites received PBS and MTT assay was done on each suspension. For evaluating the Th1-type immune responses, the serum levels of IFN-γ and nitric oxide (NO) were assessed in mice after injecting tachyzoites and miltefosine, respectively. The flow cytometry technique was performed on T. gondii tachyzoites challenged with IC50 and IC90 doses of miltefosine and unchallenged cells. DNA fragments in T. gondii tachyzoites were detected by Terminal dUTPnick-end labeling (TUNEL) method.
Results: Overall, 256, 64, 32, and 16 µg concentrations of miltefosine, respectively could kill more than 50% of viable T. gondii tachyzoites. The infected mice group, treated with miltefosine, significantly produced more IFN-γ relative to other groups (P< 0.001). Moreover, a significant difference was found in inducible NO synthase between the experimental and control groups (P<0.05). The flow cytometry results demonstrated a concentration-dependent apoptosis rate in tachyzoites incubated with miltefosine, though the necrosis rate was non-significant. DNA fragmentation analysis indicated oligonucleotides (18-200 bp) in tachyzoites treated with 11µg of miltefosine for 24, 48 and 72 h. However, this pattern was not observed in untreated control microorganisms.
Conclusion: Miltefosine could be a favorable candidate for use as a new treatment for toxoplasmosis.
2. Molan A, Nosaka K, Hunter M, Wang W. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Trop Biomed. 2019;36(4):898-925.
3. Khademvatan S, Abdizadeh R, Rahim F, Hashemitabar M, Ghasemi M, Tavalla M. Stray cats gastrointestinal parasites and its association with public health in Ahvaz City, South Western of Iran. Jundishapur J Microbiol. 2014;7(8): e11079.
4. Weiss LM, Dubey JP. Toxoplasmosis: A history of clinical observations. Int J Parasitol. 2009;39(8):895-901.
5. Saki J, Mohammadpour N, Moramezi F, Khademvatan S. Seroprevalence of Toxoplasma gondii in women who have aborted in comparison with the women with normal delivery in Ahvaz, southwest of Iran. ScientificWorldJournal. 2015;2015: 764369.
6. Xia J, Cheng X-Y, Wang X-J, Peng H-J. Association between Toxoplasma gondii types and outcomes of human infection: a meta-analysis. Acta Microbiol Immunol Hung. 2017;64(3):229-44.
7. Paquet C, Yudin MH, Allen VM, et al. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can. 2013;35(1):78-81.
8. Weiss LM. Toxoplasma gondii: The Model Apicomplexan-Perspectives and Methods Ed. 2: Elsevier Science; 2013.
9. Andrews KT, Fisher G, Skinner-Adams TS. Drug repurposing and human parasitic protozoan diseases. Int J Parasitol Drugs Drug Resist. 2014;4(2):95-111.
10. Unger C, Peukert M, Sindermann H, Hilgard P, Nagel G, Eibl H. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Cancer Treat Rev. 1990;17(2-3):243-6.
11. Khademvatan S, Gharavi MJ, Saki J. Miltefosine induces metacaspase and PARP genes expression in Leishmania infantum. Braz J Infect Dis. 2011;15(5):442-8.
12. Botero A, Keatley S, Peacock C, Thompson RA. In vitro drug susceptibility of two strains of the wildlife trypanosome, Trypanosoma copemani: A comparison with Trypanosoma cruzi. Int J Parasitol Drugs Drug Resist. 2017;7(1):34-41.
13. Khademvatan S, Gharavi M, Akhlaghi L, et al. Miltefosine Effect on Cell Death of Leishmania Infantum. Intern Med Today. 2009;15(3):13-20.
14. Schuster FL, Guglielmo BJ, Visvesvara GS. In‐vitro activity of miltefosine and voriconazole on clinical isolates of free‐living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol. 2006;53(2):121-6.
15. Seifert K, Duchêne M, Wernsdorfer WH, et al. Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica. Antimicrob Agents Chemother. 2001;45(5):1505-10.
16. Zorgi NE, Costa A, Junior AJG, do Nascimento N, de Andrade Junior HF. Humoral responses and immune protection in mice immunized with irradiated T. gondii tachyzoites and challenged with three genetically distinct strains of T. gondii. Immunol Lett. 2011;138(2):187-96.
17. Khademvatan S, Adibpour N, Eskandari A, Rezaee S, Hashemitabar M, Rahim F. In silico and in vitro comparative activity of novel experimental derivatives against Leishmania major and Leishmania infantum promastigotes. Exp Parasitol. 2013;135(2):208-16.
18. Jazani NH, Karimzad M, Mazloomi E, Sohrabpour M, Hassan ZM, Ghasemnejad H, Roshan-Milani S, Shahabi S. Evaluation of the adjuvant activity of naloxone, an opioid receptor antagonist, in combination with heat-killed Listeria monocytogenes vaccine. Microbes Infect. 2010;12(5):382-8.
19. Foroutan-Rad M, Khademvatan S, Jasem S, Hashemitabar M. Holothuria leucospilota extract induces apoptosis in Leishmania major promastigotes. Iran J Parasitol. 2016;11(3):339-349.
20. Rieger AM, Nelson KL, Konowalchuk JD, Barreda DR. Modified annexin V/propidium iodide apoptosis assay for accurate assessment of cell death. J Vis Exp. 2011; (50): 2597.
21. Asadi N, Khademvatan S, Hajipirloo HM, et al. The Cytotoxic and Immunomodulatory Effects of Titanium Dioxide Nanoparticles and Sargassum oligocystum on Toxoplasma gondii In Vitro and In Vivo. Anti Infective Agents. 2021;19(3):317-24.
22. Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med. 2007;43(5):645-57.
23. Negoescu A, Lorimier P, Labat-Moleur F, et al. In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations. J Histochem Cytochem. 1996;44(9):959-68.
24. Khademvatan S, Saki J, Khajeddin N, et al Z. Toxoplasma gondii exposure and the risk of schizophrenia. Jundishapur J Microbiol. 2014;7(11): e12776
25. Verma NK, Dey CS. Possible mechanism of miltefosine-mediated death of Leishmania donovani. Antimicrob Agents Chemother. 2004;48(8):3010-5.
26. Eissa MM, Barakat AM, Amer EI, Younis LK. Could miltefosine be used as a therapy for toxoplasmosis? Exp Parasitol. 2015;157:12-22.
27. Marinho FdA, Gonçalves KCdS, Oliveira SSd, Oliveira A-CdSCd, Bellio M, d'Avila-Levy CM, Santos ALSd, Branquinha MH. Miltefosine induces programmed cell death in Leishmania amazonensis promastigotes. Mem Inst Oswaldo Cruz. 2011;106:507-9.
28. Khademvatan S, Gharavi M, Akhlaghi L, Samadikuchaksaraei A, Mousavizadeh K, Hadighi R, Saki J. Induction of Apoptosis by Miltefosine in Iranian Strain of Leishmania infantum Promastigotes. Iran J Parasitol. 1;4(2):23-31.
29. Khademvatan S, Gharavi MJ, Rahim F, Saki J. Miltefosine-induced apoptotic cell death on Leishmania major and L. tropica strains. Korean J Parasitol. 2011;49(1):17-23.
30. Khademvatan S, Gharavi MJ, Yousefi E, Saki J. INOS and IFN gamma Gene Expression in Leishmania major-Infected J774 Cells Treated With Miltefosine. Int J Pharmacol. 2011;7(8):843-9.
| Files | ||
| Issue | Vol 19 No 1 (2024) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijpa.v19i1.15204 | |
| Keywords | ||
| Interferon-gamma Miltefosine Nitric oxide Tachyzoite Toxoplasma gondii | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
